Non-neoplastic cells as prognostic biomarkers in diffuse large B-cell lymphoma: A system review and meta-analysis
- PMID: 38183180
- DOI: 10.1177/03008916231221636
Non-neoplastic cells as prognostic biomarkers in diffuse large B-cell lymphoma: A system review and meta-analysis
Abstract
The microenvironment of diffuse large B-cell lymphoma (DLBCL) is composed of various components, including immune cells and immune checkpoints, some of which have been correlated with the prognosis of DLBCL, but their results remain controversial. Therefore, we conducted a systematic review and meta-analysis to investigate the association between the microenvironment and prognosis in DLBCL. We searched PubMed, Web of Science, and EMBASE for relevant articles between 2001 and 2022. Twenty-five studies involving 4495 patients with DLBCL were included in the analysis. This meta-analysis confirmed that high densities of Foxp3+Tregs and PD-1+T cells are good indicators for overall survival (OS) in DLBCL, while high densities of programmed cell death protein ligand1(PD-L1)-positive expression cells and T-cell immunoglobulin-and mucin domain-3-containing molecule 3 (TIM-3)-positive expression tumor-infiltrating cells (TILs) play a contrary role in OS. Additionally, higher numbers of T-cell intracytoplasmic antigen-1(TIA-1)-positive expression T cells imply better OS and progression-free survival (PFS), while high numbers of lymphocyte activation gene(LAG)-positive expression TILs predict bad OS and PFS. Various non-tumoral cells in the microenvironment play important roles in the prognosis of DLBCL.
Keywords: diffuse large B cell lymphoma; meta-analysis; prognostic biomarker; systematic review; tumor microenvironment.
Conflict of interest statement
Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Similar articles
-
Immunohistochemical expression of PD1, LAG3, and CTLA4 in diffuse large B cell lymphoma, clinicopathological correlation, and prognostic value.J Egypt Natl Canc Inst. 2025 Jun 7;37(1):47. doi: 10.1186/s43046-025-00303-0. J Egypt Natl Canc Inst. 2025. PMID: 40481915
-
Prognostic implications of the tumor immune microenvironment and immune checkpoint pathway in primary central nervous system diffuse large B-cell lymphoma in the North Indian population.APMIS. 2022 Feb;130(2):82-94. doi: 10.1111/apm.13195. Epub 2021 Dec 23. APMIS. 2022. PMID: 34862664
-
Prognostic and clinicopathological significance of PD-1/PD-L1 expression in the tumor microenvironment and neoplastic cells for lymphoma.Int Immunopharmacol. 2019 Dec;77:105999. doi: 10.1016/j.intimp.2019.105999. Epub 2019 Nov 6. Int Immunopharmacol. 2019. PMID: 31704289 Review.
-
Expression of programmed cell death ligand-1 by immune cells in the microenvironment is a favorable prognostic factor for primary diffuse large B-cell lymphoma of the central nervous system.Neuropathology. 2021 Apr;41(2):99-108. doi: 10.1111/neup.12705. Epub 2020 Dec 2. Neuropathology. 2021. PMID: 33269495
-
Prognostic value of tissue-infiltrating immune cells in tumor microenvironment of follicular lymphoma: A meta-analysis.Int Immunopharmacol. 2020 Aug;85:106684. doi: 10.1016/j.intimp.2020.106684. Epub 2020 Jun 12. Int Immunopharmacol. 2020. PMID: 32540726
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials